Aug 17, 2025, 19:29

AST Research Network — Early Faculty Development Research Grant

One-year career development grant (USD 75,000) for early faculty (within 5 years of first faculty appointment) conducting basic, translational, or clinical research in solid organ transplantation/immunology. Research must start July 1, 2026.

Eligibility Criteria:

MD/PhD/PharmD (or equivalent) with faculty appointment by July 1, 2026; within 5 years of initial faculty appointment (case-by-case extensions possible).
Active AST member (or membership application submitted by Dec 1, 2025) and research performed in North America; citizenship/permanent residency requirements apply (U.S./Canada/Mexico).
Protected time: ≥50% (basic/translational) or ≥25% (clinical).
Not eligible if PI on prior/current independent awards (e.g., NIH R01, P01 project, R21, VA Merit) or if holding concurrent K-series/R00/career development awards at application.
No scientific overlap with other AST grants from the same group; distinct from concurrent awards.

Funding Details:

USD 75,000 for 1 year; paid to the institution.
Allowable: recipient salary, project personnel, research costs.
Not allowed: institutional overhead/indirects, capital equipment, travel.
IRB/visa (if applicable) required before funds release.

Deadline:

Applications due: December 1, 2025 (11:59 p.m. Pacific).
Notifications: March 2026; recognition at ATC (June 20–24, 2026, Boston).
Project start: July 1, 2026 (no deferrals).

Where to Go for Further Information:

Apply.
Questions: [email protected].

American Society of Transplantation AST Research Network career development grant clinical research early faculty development immunology NIH readiness OncoDaily seed funding Solid organ transplant translational research Transplantation

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

New FDA PreCheck Program to Boost U.S. Drug Manufacturing